July 2018
Volume 59, Issue 9
Open Access
ARVO Annual Meeting Abstract  |   July 2018
Retinal ganglion cells are protected through hypothermia treatment in an organ culture model
Author Affiliations & Notes
  • Jose Hurst
    Research, Eye Hospital Tuebingen, T?bingen, Germany
  • Sandra Kuehn
    Ophthalmology, Ruhr-University Bochum,, Bochum, Germany
  • Ana Maliha
    Ophthalmology, Ruhr-University Bochum,, Bochum, Germany
  • Fenja Herms
    Ophthalmology, Ruhr-University Bochum,, Bochum, Germany
  • H Burkhard Dick
    Ophthalmology, Ruhr-University Bochum,, Bochum, Germany
  • Karl Ulrich Bartz-Schmidt
    Research, Eye Hospital Tuebingen, T?bingen, Germany
  • Sven Schnichels
    Research, Eye Hospital Tuebingen, T?bingen, Germany
  • Stephanie C Joachim
    Ophthalmology, Ruhr-University Bochum,, Bochum, Germany
  • Footnotes
    Commercial Relationships   Jose Hurst, None; Sandra Kuehn, None; Ana Maliha, None; Fenja Herms, None; H Burkhard Dick, None; Karl Ulrich Bartz-Schmidt, None; Sven Schnichels, None; Stephanie Joachim, None
  • Footnotes
    Support  none
Investigative Ophthalmology & Visual Science July 2018, Vol.59, 5501. doi:
  • Views
  • Share
  • Tools
    • Alerts
      ×
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      Jose Hurst, Sandra Kuehn, Ana Maliha, Fenja Herms, H Burkhard Dick, Karl Ulrich Bartz-Schmidt, Sven Schnichels, Stephanie C Joachim; Retinal ganglion cells are protected through hypothermia treatment in an organ culture model. Invest. Ophthalmol. Vis. Sci. 2018;59(9):5501.

      Download citation file:


      © ARVO (1962-2015); The Authors (2016-present)

      ×
  • Supplements
Abstract

Purpose : Cobalt is important for the neuronal integrity but high quantities induce cytotoxic mechanisms. Treatment with Cobalt-chloride (CoCl2) led to strong degeneration of porcine retina through hypoxic mechanisms. Neurons of the inner retina layers are particularly affected. In the presented project this model is used to study possible protective effects of hypothermia treatment.

Methods : Porcine retina explants were cultivated for four and eight days at 37°C. Four groups were compared: control, control+30°C, CoCl2, and CoCl2+30°C. Hypothermia (30°C) was applied in parallel to hypoxic damage using 300µM CoCl2 for 48 h. Retinal explants were subject to immunohistochemistry, qRT-PCR, and Western blot analysis. The number of retinal ganglion cells (RGC), as well as microglia, bipolar, and amacrine cells was evaluated and compared between groups.

Results :
At four days of cultivation, in the control group 30.9±1.1 Brn-3a+ cells/mm were counted, exposure with CoCl2 led to a significant loss of RGCs in the CoCl2+37 °C group (23.7±0.9 Brn-3a+ cells/mm, p<0.001). The hypothermia treatment (CoCl2+30°C) counteracted this effect, on average 27.4±1.5 Brn-3a+ cells were detected (p=0.19). Also apoptosis rate in the CoCl2+30°C group (53.2±2.4% cleaved caspase3+) was lower than in the CoCl2 +37°C group (65.6±3.2% cleaved caspase3+).
Furthermore, hypothermia treatment attenuated significantly gene expression of stress marker p21 (5-fold, after four and eight days, p<0.001) and HSP70 (23-fold after four days, 7-fold after eight days, p<0.001) compared to the CoCl2 treated group at 37°C.
The microglia degenerated in the CoCl2+37 °C group at both time points, (four days: 18.8±0.7 Iba1+cells/mm; eight days: 13.3±0.9 Iba1+cells/mm) compared to control (four days: 45.1±4.1 Iba1+cells/mm; eight days: 40.0±2.4 Iba1+cells/mm, p<0.05). Hypothermia treatment could stop this effect and rescued the number of microglia (four days: 37.1±1.7 Iba1+cells/mm, p<0.001; eight days: 19.5±0.8 Iba1+cells/mm, p=0.03).

Conclusions : The cultivation of porcine retinae with CoCl2 lead to a hypoxia-like degeneration processes. The hypothermia treatment induced cell protection and saved especially retinal ganglion cells from apoptosis. Hence, this system may serve as a first analysis model for therapy screening for retinal diseases. This alternative model is suitable for drug and treatment screening and will therefore reduce the number of animal studies.

This is an abstract that was submitted for the 2018 ARVO Annual Meeting, held in Honolulu, Hawaii, April 29 - May 3, 2018.

×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×